Media headlines about Sientra (NASDAQ:SIEN) have trended somewhat positive on Thursday, according to Accern Sentiment Analysis. The research firm rates the sentiment of news coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Sientra earned a media sentiment score of 0.20 on Accern’s scale. Accern also gave news stories about the medical instruments supplier an impact score of 46.487162738121 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

Several equities analysts have commented on the stock. BidaskClub downgraded shares of Sientra from a “hold” rating to a “sell” rating in a report on Tuesday, January 9th. Canaccord Genuity reiterated a “buy” rating and issued a $19.00 price objective on shares of Sientra in a report on Friday, January 5th. Zacks Investment Research upgraded shares of Sientra from a “sell” rating to a “hold” rating in a research note on Tuesday, January 2nd. ValuEngine upgraded shares of Sientra from a “sell” rating to a “hold” rating in a research note on Sunday, December 31st. Finally, Stifel Nicolaus restated a “hold” rating and issued a $14.00 price target (up from $11.00) on shares of Sientra in a research note on Wednesday, September 27th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and four have assigned a buy rating to the company. Sientra has a consensus rating of “Hold” and a consensus target price of $15.00.

Sientra (NASDAQ:SIEN) traded up $0.04 during mid-day trading on Thursday, hitting $11.04. 279,600 shares of the company traded hands, compared to its average volume of 220,927. The company has a debt-to-equity ratio of 0.57, a current ratio of 2.87 and a quick ratio of 1.92. Sientra has a fifty-two week low of $7.20 and a fifty-two week high of $16.68. The firm has a market capitalization of $213.42, a P/E ratio of -3.87 and a beta of -1.47.

Sientra (NASDAQ:SIEN) last released its quarterly earnings results on Tuesday, November 7th. The medical instruments supplier reported ($0.74) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.68) by ($0.06). Sientra had a negative net margin of 169.77% and a negative return on equity of 68.82%. The business had revenue of $9.80 million during the quarter, compared to analyst estimates of $10.54 million. During the same quarter last year, the company posted ($0.55) earnings per share. The company’s revenue was up 50.8% on a year-over-year basis. equities research analysts anticipate that Sientra will post -3.23 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: This report was first reported by Daily Political and is owned by of Daily Political. If you are accessing this report on another domain, it was stolen and reposted in violation of U.S. & international copyright legislation. The legal version of this report can be read at

Sientra Company Profile

Sientra, Inc is a medical aesthetics company. The Company’s primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures, which it offers in over 190 variations of shapes, sizes and textures. The Company sells its breast implants and breast tissue expanders, or breast products to plastic surgeons.

Insider Buying and Selling by Quarter for Sientra (NASDAQ:SIEN)

Receive News & Ratings for Sientra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra and related companies with's FREE daily email newsletter.